Procter & Gamble Hygiene and Health Care · NSE: PGHH · BSE: 500459
Q4 FY24 results · Jan–Mar 2024
Procter & Gamble Hygiene and Health Care reported revenue from operations of ₹1,002.17 crore (up 13.5% from Q4 FY23) and net profit of ₹154.37 crore (down 6.5% from Q4 FY23) for Q4 FY24 (Jan–Mar 2024), on a standalone basis.
| Item | Q4 FY24 | Q4 FY23 | YoY | Q3 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,002.17 | 883.09 | +13.5% | 1,133.43 | −11.6% |
| Other income | 13.59 | 14.44 | −5.9% | 15.58 | −12.8% |
| Total income | 1,015.76 | 897.53 | +13.2% | 1,149.01 | −11.6% |
| Profit before tax | 233.94 | 145.56 | +60.7% | 308.51 | −24.2% |
| Net profit for the period | 154.37 | 165.02 | −6.5% | 228.90 | −32.6% |
| EPS, basic (₹) | 47.56 | 50.84 | −6.5% | 70.51 | −32.5% |
| Net margin (%) | 15.4 | 18.7 | 20.2 |
Standalone
- Filed with BSE
- 02 May 2024, 11:12 IST
- Board meeting
- 30 Apr 2024
- Period
- 01 Jan 2024 to 31 Mar 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE